Synergistic Impact of Dual-Targeted Therapies with Chemotherapy Achieves Promising Response Rates in BRAF-Mutated Metastatic Colorectal Cancer
In recent advancements in the treatment of metastatic colorectal cancer (mCRC) characterized by BRAF V600E mutations, researchers have announced compelling ...